Involvement of IGF-1 and Akt in M1/M2 activation state in bone marrow-derived macrophages

Experimental Cell Research

Volumn 335, Issue 2, 2015, Pages 258-268

  Barrett, James P ^a   Minogue, Aedín M ^a   Falvey, Aidan ^a   Lynch, Marina A ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Akt; ; BMDMs; ; IFN ; IGF 1; ; IL 4;

Indexed keywords

ARGINASE 1; CHITINASE; CHITINASE 3 LIKE 3; FOUND IN INFLAMMATORY ZONE 1 PROTEIN; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR TYPE I; INTERLEUKIN 4 RECEPTOR TYPE II; JANUS KINASE 3; MANNOSE RECEPTOR; MANNOSE RECEPTOR 1; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; SOMATOMEDIN C; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; JAK3 PROTEIN, MOUSE; TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IMMUNOSTIMULATION; MACROPHAGE ACTIVATION; MACROPHAGE CULTURE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL CULTURE; ENZYMOLOGY; IMMUNOLOGY; MACROPHAGE; METABOLISM; PHYSIOLOGY;

ANIMALS; CELLS, CULTURED; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-4; JANUS KINASE 3; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84937630928     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2015.05.015     Document Type: Article

References (30)

1. Stein M., Keshav S., Harris N., Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 1992, 176:287-292.
2. Martinez F.O., Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000prime Rep. 2014, 6:13.
3. Townsend K.P., Town T., Mori T., Lue L.F., Shytle D., et al. CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Eur. J. Immunol. 2005, 35:901-910.
4. Chinetti-Gbaguidi G., Baron M., Bouhlel M.A., Vanhoutte J., Copin C., et al. Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARgamma and LXRalpha pathways. Circ. Res. 2011, 108:985-995.
5. Barrett J.P., Minogue A.M., Jones R.S., Ribeiro C., Kelly R.J., Lynch M.A. Bone marrow-derived macrophages from AbetaPP/PS1 mice are sensitized to the effects of inflammatory stimuli. J. Alzheimer's Dis. 2014.
6. Varin A., Gordon S. Alternative activation of macrophages: immune function and cellular biology. Immunobiology 2009, 214:630-641.
7. Heller N.M., Qi X., Junttila I.S., Shirey K.A., Vogel S.N., et al. Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages. Sci. Signal. 2008, 1:ra17.
8. Arkins S., Rebeiz N., Brunke-Reese D.L., Biragyn A., Kelley K.W. Interferon-gamma inhibits macrophage insulin-like growth factor-I synthesis at the transcriptional level. Mol. Endocrinol. 1995, 9:350-360.
9. Downer E.J., Cowley T.R., Cox F., Maher F.O., Berezin V., et al. A synthetic NCAM-derived mimetic peptide, FGL, exerts anti-inflammatory properties via IGF-1 and interferon-gamma modulation. J. Neurochem. 2009, 109:1516-1525.
10. Maher F.O., Nolan Y., Lynch M.A. Downregulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in the aged rat. Neurobiol. Aging 2005, 26:717-728.
11. Minogue A.M., Barrett J.P., Lynch M.A. LPS-induced release of IL-6 from glia modulates production of IL-1beta in a JAK2-dependent manner. J. Neuroinflamm. 2012, 9:126.
12. Ruckerl D., Jenkins S.J., Laqtom N.N., Gallagher I.J., Sutherland T.E., et al. Induction of IL-4Ralpha-dependent microRNAs identifies PI3K/Akt signaling as essential for IL-4-driven murine macrophage proliferation in vivo. Blood 2012, 120:2307-2316.
13. Wynes M.W., Riches D.W. Induction of macrophage insulin-like growth factor-I expression by the Th2 cytokines IL-4 and IL-13. J. Immunol. 2003, 171:3550-3559.
14. Junttila I.S., Mizukami K., Dickensheets H., Meier-Schellersheim M., Yamane H., et al. Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity. J. Exp. Med. 2008, 205:2595-2608.
15. Luyendyk J.P., Schabbauer G.A., Tencati M., Holscher T., Pawlinski R., Mackman N. Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J. Immunol. 2008, 180:4218-4226.
16. Haque S.J., Harbor P., Tabrizi M., Yi T., Williams B.R. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J. Biol. Chem. 1998, 273:33893-33896.
17. Sanson M., Distel E., Fisher E.A. HDL induces the expression of the M2 macrophage markers arginase 1 and Fizz-1 in a STAT6-dependent process. PloS One 2013, 8:e74676.
18. Takeda K., Kamanaka M., Tanaka T., Kishimoto T., Akira S. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J. Immunol. 1996, 157:3220-3222.
19. Welch J.S., Escoubet-Lozach L., Sykes D.B., Liddiard K., Greaves D.R., Glass C.K. TH2 cytokines and allergic challenge induce Ym1 expression in macrophages by a STAT6-dependent mechanism. J. Biol. Chem. 2002, 277:42821-42829.
20. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
21. Suh H.S., Zhao M.L., Derico L., Choi N., Lee S.C. Insulin-like growth factor 1 and 2 (IGF1, IGF2) expression in human microglia: differential regulation by inflammatory mediators. J. Neuroinflammation 2013, 10:37.
22. Madathil S.K., Carlson S.W., Brelsfoard J.M., Ye P., D'Ercole A.J., Saatman K.E. Astrocyte-specific overexpression of insulin-like growth factor-1 protects hippocampal neurons and reduces behavioral deficits following traumatic brain injury in mice. PloS One 2013, 8:e67204.
23. Li S.L., Overman J.J., Katsman D., Kozlov S.V., Donnelly C.J., et al. An age-related sprouting transcriptome provides molecular control of axonal sprouting after stroke. Nat. Neurosci. 2010, 13:1496-1504.
24. Riedemann J., Macaulay V.M. IGF1R signalling and its inhibition. Endocr. Relat. Cancer 2006, 13(Suppl. 1):S33-S43.
25. O'Donnell S.L., Frederick T.J., Krady J.K., Vannucci S.J., Wood T.L. IGF-I and microglia/macrophage proliferation in the ischemic mouse brain. Glia 2002, 39:85-97.
26. Weisser S.B., McLarren K.W., Voglmaier N., van Netten-Thomas C.J., Antov A., et al. Alternative activation of macrophages by IL-4 requires SHIP degradation. Eur. J. Immunol. 2011, 41:1742-1753.
27. Medina E.A., Morris I.R., Berton M.T. Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain. J. Immunol. 2010, 185:7562-7572.
28. Schabbauer G., Tencati M., Pedersen B., Pawlinski R., Mackman N. PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1963-1969.
29. Williams D.L., Li C., Ha T., Ozment-Skelton T., Kalbfleisch J.H., et al. Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J. Immunol. 2004, 172:449-456.
30. Minogue A.M., Jones R.S., Kelly R.J., McDonald C.L., Connor T.J., Lynch M.A. Age-associated dysregulation of microglial activation is coupled with enhanced blood-brain barrier permeability and pathology in APP/PS1 mice. Neurobiol. Aging 2014, 35:1442-1452.